Join us for an audio catch-up on the major events in the global biopharma industry over the past business week, as reported by Scrip‘s global team, in this podcast version of Five Must-Know Things.
This episode covers insights for the business week ended 2 May 2025, including: AstraZeneca CEO cautions Europe; Pfizer CEO optimistic on US tariffs, pricing; Merck & Co reassures on pipeline; Merck KGaA buys SpringWorks; and Akeso explains ivonescimab overall survival data.
This and all our other podcasts are available on the Citeline channel on Apple Podcasts, SoundCloud, TuneIn and Spotify Podcasts, and via smart speakers if one of these platforms has been set up as your default podcast provider.
Stories mentioned in this episode:
- Soriot Cautions Europe Amid More US Expansion
- Pfizer CEO Bourla ‘Cautiously Optimistic’ About Tariffs, Pricing Policies
- Merck & Co. CMO Eliav Barr Assures On Pipeline As Keytruda LOE Looms Large
- Merck KGaA Seals SpringWorks Buy
- Akeso Explains Ivonescimab Prelim OS Data After Investors’ Negative Reactions